MAPT and Alzheimer disease: Different in the newest criteria is that T status is has been divided into 2 subcategories: T1 which becomes abnormal at a similar time as A status and in which phosphorylated/secreted AD tau is measured, and T2 which becomes abnormal later in the disease, is more closely linked to the onset of symptoms, and in which AD tau proteinopathy is measured.